1. Home
  2. DIAX vs USNA Comparison

DIAX vs USNA Comparison

Compare DIAX & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIAX
  • USNA
  • Stock Information
  • Founded
  • DIAX 2005
  • USNA 1992
  • Country
  • DIAX United States
  • USNA United States
  • Employees
  • DIAX N/A
  • USNA N/A
  • Industry
  • DIAX Finance Companies
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • DIAX Finance
  • USNA Health Care
  • Exchange
  • DIAX Nasdaq
  • USNA Nasdaq
  • Market Cap
  • DIAX 477.5M
  • USNA 461.9M
  • IPO Year
  • DIAX N/A
  • USNA 1996
  • Fundamental
  • Price
  • DIAX $14.01
  • USNA $29.51
  • Analyst Decision
  • DIAX
  • USNA Hold
  • Analyst Count
  • DIAX 0
  • USNA 1
  • Target Price
  • DIAX N/A
  • USNA $36.00
  • AVG Volume (30 Days)
  • DIAX 96.6K
  • USNA 225.3K
  • Earning Date
  • DIAX 01-01-0001
  • USNA 04-22-2025
  • Dividend Yield
  • DIAX 7.93%
  • USNA N/A
  • EPS Growth
  • DIAX N/A
  • USNA N/A
  • EPS
  • DIAX N/A
  • USNA 1.82
  • Revenue
  • DIAX N/A
  • USNA $876,242,000.00
  • Revenue This Year
  • DIAX N/A
  • USNA $13.04
  • Revenue Next Year
  • DIAX N/A
  • USNA $7.36
  • P/E Ratio
  • DIAX N/A
  • USNA $16.36
  • Revenue Growth
  • DIAX N/A
  • USNA N/A
  • 52 Week Low
  • DIAX $12.80
  • USNA $23.10
  • 52 Week High
  • DIAX $15.12
  • USNA $49.78
  • Technical
  • Relative Strength Index (RSI)
  • DIAX 52.21
  • USNA 64.50
  • Support Level
  • DIAX $13.88
  • USNA $27.82
  • Resistance Level
  • DIAX $14.17
  • USNA $29.84
  • Average True Range (ATR)
  • DIAX 0.16
  • USNA 1.14
  • MACD
  • DIAX 0.07
  • USNA 0.43
  • Stochastic Oscillator
  • DIAX 83.33
  • USNA 93.43

About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest

Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Share on Social Networks: